<?xml version="1.0" encoding="UTF-8"?>
<references>
<reference>
  <a1>Inamdar, Kedar V.</a1>
  <a2>Romaguera, Jorge E.</a2>
  <a2>Drakos, Elias</a2>
  <a2>Knoblock, Ronald J.</a2>
  <a2>Garcia, Mar</a2>
  <a2>Leventaki, Vasiliki</a2>
  <a2>Medeiros, L. Jeffrey</a2>
  <a2>Rassidakis, George Z.</a2>
  <t1>Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine</t1>
  <t2>Cancer</t2>
  <sn/>
  <op/>
  <vo/>
  <ab/>
  <la>eng</la>
  <k1/>
  <pb/>
  <pp/>
  <yr>2009</yr>
  <ed/>
  <ul>http://zaguan.unizar.es/record/130506/files/texto_completo.pdf;
	http://zaguan.unizar.es/record/130506/files/texto_completo.jpg?subformat=icon;
	</ul>
  <no>Imported from Invenio.</no>
</reference>

</references>